MaRS Innovation Corporate Deck (Autumn 2015)
•
2 likes•2,577 views
This deck provides an overview of MaRS Innovation, its members and portfolio, along with the commercialization services that we provide to help technology being developed by member researchers to reach the market. Our two primary paths are creating start-up companies or negotiating license deals.
Recommended
Recommended
More Related Content
Recently uploaded
Recently uploaded (20)
Featured
Featured (20)
MaRS Innovation Corporate Deck (Autumn 2015)
- 1. Corporate Presentation Deck Autumm 2015 Canada’s CECR Program: A Novel Approach to Commercializing Canadian Innovations
- 2. We exist to harness Canada’s largest research cluster 15 MEMBERS = ONE VISION Filler filler filler filler And turn the $1.47 billion annually invested into basic research within our members into market-facing products and services
- 3. WHY WERE WE CREATED? In partnership with our members, MaRS Innovation exists to bridge academic excellence and market-driven success. Valley of Death: Early commercialization stage where promising ideas fail
- 6. SERVICES TO MEMBERS Support Standard Services Screen Light Touch: One-to-Many Build High-Touch: Dedicated License Team Launch Highest Touch: Up to 50 Per Cent Dedicated Time to Start-Up Company Access to Resources: • Market intelligence • MI’s network • Discipline-specific expertise Validation Funding: • Proof-of-Principle funding • Industry matching funds • Scouting services Deal Team Services: • Intellectual property management • Commercial development and negotiations Company Creation: • Embedded management • Business strategy and development • External investment and negotiations
- 9. Protected—Commercial Confidential PORTFOLIO DIVERSITY MaRS Innovation accepts member technologies in: Therapeutics Physical sciences Clean Technology Medical devices and medical diagnostics Information and communications technology (ICT)
- 10. Company Creation Drug Development Diagnostics/ Medical Devices E-Health DLVR Beside Clinical Systems BlueDot Encycle BresoTec eQOL * Formation ChipCare E-Twenty * ScarX Kapplex Root2Crown * Triphase Legworks Syncadian * Ubiquitech OtoSIm Treata * Vasomune Xagenic TrendMD * Zucara XLV Diagnostics VitalHub * UTEST company ** Equity acquired through license transaction LIFE SCIENCES PORTFOLIO COMPANIES
- 11. Information Technology Physical Sciences Crowdmark * FlatFab * CoursePeer * ICE3 * Flybits QD Solar Granata DS * * * Kaypok Wearables Nvest * Onyx Motion * Shotl:st * Whirlscape * Thotra * Slyce ** PHYSICAL SCIENCES PORTFOLIO COMPANIES Company Creation * UTEST company ** Equity acquired through license transaction * * * Acquired
- 13. PORTFOLIO INVESTORS • BDC Venture Capital • Bernard M. Gordon Unitrust • CTI Life Sciences Fund • Domain Associates, LLC • Epic Capital • Horizons Ventures • Lumira Capital • Maple Leaf Angels • Puffin Partners • Qiagen, NV • Robert Bosch Venture Capital • Takeda Ventures • Trellis Capital • Vodafone • Winfield Venture Group • Ycombinator • Other angel groups and private trusts Blue indicates foreign investor groups that have funded MI start-up companies.
- 14. COMPANY & JOB STATISTICS Secured Angel Funds Completed Series A Negotiating Series A Completed Series B Revenue / Major Contracts Strategic Investor/Partners Acquisition/exit 8 5 7 2 7 6 1 MI Start-Up Companies 300+ direct jobs created (no multiplier) 37 / 38 MaRS Innovation start-up companies remain in Canada
- 15. PORTFOLIO LEVERAGESTART-UP COMPANY Over 10x leverage $10 million MaRS Innovation’s investment into our portfolio companies $125 million External investment into the portfolio ($94 million foreign investment)
- 16. THANK YOU Web: marsinnovation.com Twitter: @marsinnovation LinkedIn: http://linkd.in/Lk7JoJ
Editor's Notes
- VOICEOVER: If MI doesn’t exist, very little of the technologies we see will cross over; no other private investors play in this space because it is SO RISKY and 5 years early. If we aren’t here to mobilize our research sector, it’s not happening.
- These are the member institutions with whom we work.
- The further a project advances, the
- *UTEST stands for University of Toronto Early Stage Technology program. It provides nascent software companies with start-up funding, office space in the MaRS Discovery District facility, mentoring and business strategy support. UTEST accepts companies in the very earliest stages of idea generation— before they’re ready for traditional incubators — and awards each company up to $30,000 in start-up funds. UTEST is jointly administered by the Innovations & Partnerships Office at the University of Toronto and MaRS Innovation.
- Angels: Avid, Apnea, Chipcare, Legworks, ScarX, TrendMD, VitalHub, Whirlscape Series A: Xagenic, XLV, BlueDot, Flybits and Chipcare Series B: Xagenic Revenue/Contracts: Otosim, VitalHub, Flybits and BlueDot Strategic industry partners/investor: Encycle, Triphase, Vasomune
- Angels: Formation, Apnea, Chipcare, Legworks, ScarX, TrendMD, VitalHub, Whirlscape Series A: Xagenic, XLV, BlueDot, Flybits and Chipcare Series B: Xagenic, Triphase Revenue/Contracts: Otosim, VitalHub, Flybits, BlueDot, Whirlscape, Crowdmark, TrendMD Strategic industry partners/investor: Encycle, Triphase, Vasomune, VitalHub, BlueDot, Flybits
- Please adjust this slide to look less crappy. Increasing traction: Four out of five Series A investments have come in the last year